TG Therapeutics Inc (TGTX) Announces Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
TG Therapeutics, Inc. (TGTX)
Last tg therapeutics, inc. earnings: 11/12 07:34 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.tgtherapeutics.com
Company Research
Source: Yahoo! Finance
Operating Loss : Q4 saw an operating loss of $12.5 million, but the full year ended with an operating income of $20.6 million. Net Loss : TGTX reported a net loss of $14.4 million in Q4 and a net income of $12.7 million for the full year. Research and Development : R&D expenses totaled $17.4 million for Q4 and $76.2 million for the full year. Cash Position : The company ended the year with $217.5 million in cash, cash equivalents, and investment securities. Equity Increase : Total equity improved significantly to $160.5 million at year-end from $58.6 million the previous year. Warning! GuruFocus has detected 4 Warning Signs with TGTX. On February 28, 2024, TG Therapeutics Inc ( NASDAQ:TGTX ) released its 8-K filing , detailing the financial outcomes for the fourth quarter and the full year of 2023. The company, a commercial-stage biopharmaceutical entity, is known for its focus on novel treatments for B-cell diseases. TG Therapeutics has recently seen the U.S. Food and Dr
Show less
Read more
Impact Snapshot
Event Time:
TGTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TGTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TGTX alerts
High impacting TG Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
TGTX
News
- TG Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- TG Therapeutics Provides Business Update and Reports First Quarter 2024 Financial ResultsGlobeNewswire
- TG Therapeutics to Host Conference Call on First Quarter 2024 Financial Results and Business UpdateGlobeNewswire
- TG Therapeutics, Inc. (NASDAQ: TGTX) had its "buy" rating re-affirmed by analysts at LADENBURG THALM/SH SH. They now have a $39.00 price target on the stock.MarketBeat
- TG Therapeutics, Inc. (NASDAQ: TGTX) had its "overweight" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $25.00 price target on the stock.MarketBeat
TGTX
Earnings
- 5/1/24 - Miss
TGTX
Sec Filings
- 5/1/24 - Form 8-K
- 4/29/24 - Form ARS
- 4/29/24 - Form DEFA14A
- TGTX's page on the SEC website